Table 1 Clinico-pathological characteristics in 261 patients of lung adenocarcinomas
From: Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression
| Â | N | % |
|---|---|---|
Gender | ||
 Male | 131 | 50.2 |
 Female | 130 | 49.8 |
Histological types (predominant components) | ||
 Acinar | 90 | 34.5 |
 Lepidic | 14 | 5.4 |
 Micropapillary | 22 | 8.4 |
 Mucinous | 10 | 3.8 |
 Papillary | 66 | 25.3 |
 Solid | 59 | 22.6 |
ALK fusion gene | ||
 Positive | 17 | 6.5 |
 Negative | 244 | 93.5 |
EGFR Status | ||
 Mutated | 154 | 59 |
 Wild-typed | 107 | 41 |
Clinical Stage | ||
 IA | 69 | 26.4 |
 IB | 27 | 10.3 |
 IIA | 7 | 2.7 |
 IIB | 14 | 5.4 |
 IIIA | 79 | 30.3 |
 IIIB+IV | 65 | 24.9 |